Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease state associated with glutamate dysfunction.
吡唑吡啶,
吡唑吡嗪,
吡唑嘧啶,
吡唑噻吩和
吡唑噻唑化合物可用作代谢型谷
氨酸受体亚型4(mGluR4)的别构势化剂/正别构调节剂;制备这些化合物的合成方法;包含这些化合物的药物组合物;以及使用这些化合物的方法,例如用于治疗神经系统和精神疾病或其他与谷
氨酸功能紊乱有关的疾病状态。